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Introduction {#sec1}
============

The *C*-nucleoside antibiotics ([Figure 1](#fig1){ref-type="fig"}) constitute an important sub-group of microbial natural products with unusual structural features and diverse biological activities ([@bib7], [@bib15]). Their biosynthesis generally follows a succinct logic, with sequential modifications of simple precursors originating from primary metabolism ([@bib6], [@bib7], [@bib21], [@bib27], [@bib32]). Less typically, minimycin (MIN, also called oxazinomycin) is produced by diverse bacterial strains, either *Streptomyces* sp. or *Pseudomonas* sp., and shows prominent antimicrobial activities against both Gram-positive and Gram-negative bacteria ([@bib12], [@bib31]). It has also demonstrated antitumor activity against transplantable tumors ([@bib12]).Figure 1Chemical Structures of Representative *C-*Nucleoside Antibiotics and IndigoidineSeveral *C-*nucleoside antibiotics (MIN-showdomycin, group I; pyrazofurin-formycin, group II; malayamycin-pseudouridimycin, group III) shown are deduced to employ distinct enzymatic logics for the assembly of the *C-*glycosidic bond. The structure of indigoidine is highlighted in blue to represent its intrinsic color.

MIN is structurally similar to pseudouridine, a modified nucleoside that is found abundantly in tRNA ([@bib13]). The MIN molecule has a unique structural feature in which a 1,3-oxazine 2,4-dione ring and a ribosyl sugar are linked via a *C*-glycoside bond ([@bib25]) ([Figure 1](#fig1){ref-type="fig"}). Previous metabolic labeling studies have shown that the ribosyl portion of MIN derives directly from D-ribose ([@bib8], [@bib9]), and C-6, C-5, and C-4 of the oxazine ring arise from the corresponding C-3, C-4, and C-5 of L-glutamate ([@bib9]). Metabolic feeding experiments by Isono et al. showed that the C-2 of MIN is derived from carbon dioxide ([@bib8]). Concomitant chemical synthesis of MIN was also achieved, with the finding that the synthetic form of MIN shares identical biological features with that from microbial source ([@bib2]).

Indigoidine ([Figure 1](#fig1){ref-type="fig"}) is a bipyridyl pigment that was first documented as a microbial natural product in the 1960s ([@bib11]), and later discovered to be produced by surprisingly diverse microbes ([@bib5], [@bib28]). The indigoidine biosynthetic gene cluster was initially reported from *Dickeya dadantii* (formerly known as *Erwinia chrysanthemi*), and it was revealed that it has important roles in pathogenicity and self-resistance to oxidative stress ([@bib23]). The gene for indigoidine biosynthesis was later identified from diverse *Streptomyces* strains ([@bib18], [@bib20], [@bib35]). A single module non-ribosomal peptide synthetase (NRPS), which selectively recognizes L-glutamine as the starter substrate, was necessary for indigoidine biosynthesis ([@bib1], [@bib30]). The indigoidine NRPS gene was subsequently engineered as a promising tool for synthetic biology purposes, either for natural product discovery ([@bib19]) or as a reporter system ([@bib16], [@bib24], [@bib34]). More recently, Ankanahalli et al. have created a transgenic blue rose by introduction of a bacterial indigoidine biosynthesis gene (*idgS*) and a phosphopantetheinyl transferase gene (*sfp*) from surfactin biosynthesis ([@bib17]).

In the present study, we address the biosynthesis of *C*-nucleoside MIN and indigoidine in *Streptomyces hygroscopicus* JCM 4712. We report that a minimal 5-gene cluster is essential for MIN biosynthesis and show that the divergent biosynthesis of MIN and indigoidine is mediated by an NRPS, MinA. Moreover, we reveal that the *N-*terminal phosphatase domain of MinC (called MinC~N~), the MinD uracil phosphoribosyltransferase, and the MinT transporter are safeguard enzymes, which collaboratively constitute an unusual self-resistance system, in which MinD likely employs an unprecedented substrate-competition strategy for self-resistance by increasing the UMP pool *in vivo*. Our deciphering of the *C*-nucleoside MIN pathway expands current understanding regarding natural product biosynthesis and self-resistance.

Results and Discussion {#sec2}
======================

Identification of MIN Biosynthetic Gene Cluster from *S. hygroscopicus* JCM 4712 {#sec2.1}
--------------------------------------------------------------------------------

To identify the gene cluster responsible for MIN biosynthesis, the genome of *S. hygroscopicus* JCM 4712 was sequenced using the Illumina Hiseq 4000 method, which renders 8.8-Mb data (G + C content 70.31%) after assembly of clean reads. MIN contains a *C*-glycosidic bond that is structurally similar to that of pseudouridine and showdomycin ([@bib21]) ([Figure 1](#fig1){ref-type="fig"}), implying that they should employ similar enzymatic logic for *C*-glycosidic bond formation. We therefore utilize pseudouridine 5′-phosphate glycosidase YeiN (GenBank: [CAQ32570.1](ncbi-p:CAQ32570.1){#intref0010}) and *C*-glycosynthase SdmA (GenBank: KKZ73237.1) as query sequences to conduct individual BLASTP analysis, leading to the discovery of two homologs ORF5178 (designated as MinB, 46%/49% identities to YeiN/SdmA) ([Table 1](#tbl1){ref-type="table"}) and ORF3816 (46%/46% identities to YeiN/SdmA) from the genome of *S. hygroscopicus* JCM 4712 (GenBank: MN397911). On the genomic region surrounding *minB* is a closely linked gene coding for a non-ribosomal peptide synthetase (MinA) ([Figure 2](#fig2){ref-type="fig"}A). The *orf3816* gene is linked with a kinase gene (GenBank: MN397911), which is identical to the YeiN-YeiC cascade for the pseudouridine metabolic pathway in *E. coli* ([@bib22]). These data suggest that the target region (*min*) covering *minA* and *minB* is likely to be involved in MIN biosynthesis.Table 1Deduced Functions of the Open Reading Frames in the *min* Gene ClusterProteinaaProtein FunctionHomolog, OriginIdentity, Similarity (%)Accession No.MinR211FadR family transcriptional regulatorSAMN05444521_6508, *Streptomyces* sp. 3124.687, 94SHI26670MinT419MFS transporterSAMN05444521_6509, *Streptomyces* sp. 3124.679, 85SHI26674MinA1379NRPS(A-Ox-T-TE-Tau)IndC, *S. chromofuscus* ATCC 4998274, 82AFV27434MinB317*C*-glycosynthaseIndA, *S. chromofuscus* ATCC 4998288, 93AFV27435MinC613HAD phosphatase and DUF4243 domainIndB, *S. chromofuscus* ATCC 4998277, 84AFV27436MinD240Uracil phosphoribosyltransferaseOrf2, *S. chromofuscus* ATCC 4998281, 90AFV27437Figure 2Genetic Organization and Investigation of the *min* Gene Cluster(A) Genetic organization of the MIN gene cluster; A, adeylation domain; Ox, oxidase domain; T, thiolation domain; TE, thioesterase domain; Tau, tautomerase domain.(B) Bioassays of the metabolites produced by related recombinants of *S. coelicolor* M1154. The indicator strain is *Bacillus subtilis*.(C) HPLC analysis of the metabolites produced by related recombinants of *S. coelicolor* M1154. Std, the authentic standard of MIN; pCHW301, the metabolites of the recombinant *S. coelicolor* M1154 containing pCHW301; *ΔminA*, the metabolites of the recombinant *S. coelicolor* M1154 containing pCHW301*ΔminA*, and other samples are correspondingly assigned; pSET152, the metabolites of the recombinant *S. coelicolor* M1154 containing pSET152 as negative control. The aliphatic numbers correspond to those in the bioassay plate.See also [Figures S1--S3](#mmc1){ref-type="supplementary-material"}; [Tables 1](#tbl1){ref-type="table"} and [S1--S4](#mmc1){ref-type="supplementary-material"}.

To determine the identity of the *min* gene cluster, we directly cloned a ca. 11.2-kb region (likely housing the whole *min* gene cluster) using a two-step PCR strategy ([Figure S1](#mmc1){ref-type="supplementary-material"}A; [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}). After confirmation ([Figure S1](#mmc1){ref-type="supplementary-material"}B), the resultant plasmid pCHW301 was transferred into *Streptomyces coelicolor* M1154 ([@bib4]). The positive conjugants (*S. coelicolor* M1154::pCHW301) were then fermented for metabolite analysis. A bioassay indicated that the samples of M1154::pCHW301 show apparent inhibition against the indicator strain *Bacillus subtilis*, but the negative control (*S. coelicolor* M1154::pSET152) lacks related bioactivity ([Figure S1](#mmc1){ref-type="supplementary-material"}C). High-performance liquid chromatography (HPLC) analysis showed that the sample of M1154::pCHW301 contains a new peak, which is absent from that of the negative control ([Figure S1](#mmc1){ref-type="supplementary-material"}D). Further liquid chromatography-mass spectrometry (LC-MS) analysis shows that the LC peak is able to generate a characteristic \[M + H\]^+^ ion at *m/z* 246.0609, with major fragment ions at *m/z* 155.9695, 210.1091, and 228.0699, fully consistent with the theoretical fragmentation pattern of MIN ([Figures S1](#mmc1){ref-type="supplementary-material"}E--S1G).

To confirm the identity of the target metabolite accumulated by M1154::pCHW301, it was HPLC purified for 1D and 2D NMR analysis. As anticipated, the 1D NMR data of the target metabolite are closely matched to those of MIN ([Figures S2](#mmc1){ref-type="supplementary-material"}A and S2B), and further detailed assignments of the compound as MIN are supported by ^1^H-^1^H COSY (Correlation Spectroscopy) and HMBC (Heteronuclear Multiple Bond Correlation) spectra ([Figures S2](#mmc1){ref-type="supplementary-material"}C and S2D). Analysis of the COSY NMR data led to the identification of a single isolated proton spin system corresponding to the ribose moiety (C-5′, C-4′, C-3′, C-2′, and C-1′), from which the relative configuration was determined based on the analysis of coupling constants. The connection between the ribose moiety and (2H)-1,3-oxazine-2,4-(3H)-dione subunit was deduced from HMBC correlations of H-6 with C-1′; H-1′ with C-4 and C-6; and H-2′ with C-5 ([Table S3](#mmc1){ref-type="supplementary-material"}). Accordingly, the structure of the target metabolite was determined to be the same as that of MIN as shown. Taken together, these data demonstrate that the target gene cluster is responsible for the biosynthesis of MIN.

The Minimal 5-Gene (*minTABCD*) Cluster Is Essential for MIN Biosynthesis {#sec2.2}
-------------------------------------------------------------------------

*In silico* analysis revealed that the target 11.2-kb region (included in pCHW301) containing six genes is deduced to be involved in MIN biosynthesis. MinR shows 87% identity to SAMN05444521_6508 of *Streptomyces* sp. 3124.6, which is likely a FadR family transcriptional regulator. The second gene, *minT*, codes for an MFS transporter with high homology (79% identity) to SAMN05444521_6509 of *Streptomyces* sp. 3124.6 ([Table 1](#tbl1){ref-type="table"}), which is proposed to transport the antibiotic out of the producer cell. The *minA* product displays significant homology (74% identities in total) to IndC, an NRPS protein from *Streptomyces chromofuscus* ATCC 49982, and the domain architectures of both enzymes are highly matched ([Table 1](#tbl1){ref-type="table"}). MinB is shown to be homologous to IndA (pseudouridine-5′-phosphate glycosidase) with 88% identities ([Table 1](#tbl1){ref-type="table"}). Moreover, *in silico* analysis shows that MinC possesses 77% identities to IndB of *S. chromofuscus* ATCC 49982 ([Table 1](#tbl1){ref-type="table"}). Notably, *minC* encodes a 613-amino acid protein containing two domains, an *N-*terminal HAD phosphatase domain and the *C-*terminal DUF4243 domain with unassigned function. Concerning MinD, it shows 81% identity to Orf2 (uracil phosphoribosyltransferase) of *S. chromofuscus* ATCC 49982 ([Table 1](#tbl1){ref-type="table"}).

To precisely pinpoint the minimal gene cluster for MIN biosynthesis, we individually mutated the target genes by an *in vitro* CRISPR-Cas9 system ([@bib14]). After confirmation ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B; [Tables S2](#mmc1){ref-type="supplementary-material"} and [S4](#mmc1){ref-type="supplementary-material"}), the pCHW301 variants were conjugated into *S. coelicolor* M1154, and the resultant recombinants were fermented for further metabolite analysis. The antibacterial bioassay indicated that all the samples, with the exception for those of M1154::pCHW301 and M1154::pCHW301*ΔminR*, lack bioactivities against the *Bacillus subtilis* indicator strain ([Figure 2](#fig2){ref-type="fig"}B). Moreover, reverse-phase HPLC analysis indicated that the sample from M1154::pCHW301*ΔminR* could also produce the distinctive peak for MIN ([Figure 2](#fig2){ref-type="fig"}C), whose identity was further confirmed by LC-MS analysis ([Figures S3](#mmc1){ref-type="supplementary-material"}C--S3F), suggesting that MIN biosynthesis is not under strict regulation by *minR* in *S. coelicolor*. These data demonstrate that a minimal 5-gene cluster (*minTABCD*) is essential for the maintenance of MIN biosynthesis.

Reconstitution of the MinA-Mediated Pathway for Indigoidine Biosynthesis {#sec2.3}
------------------------------------------------------------------------

Bioinformatic analysis showed that MinA is a typical NRPS protein containing multiple A-Ox-T-TE-Tau domains ([Figure S4](#mmc1){ref-type="supplementary-material"}A; [Table 1](#tbl1){ref-type="table"}). More surprisingly, MinA homologs had been previously characterized as the indigoidine synthetases ([@bib30]) ([Figure 3](#fig3){ref-type="fig"}A), and we were therefore curious about how this enzyme is utilized to build MIN. To evaluate the functional role of MinA, the *minA* sequence was optimized on the basis of *E. coli* preference ([Table S5](#mmc1){ref-type="supplementary-material"}), and the resultant plasmid pET28a/*minA\** (\*signifies the optimized sequence) was transferred into *E. coli* for protein overexpression and metabolite analysis. As anticipated, the broth of the *E. coli* recombinant showed a distinctive blue color (indigo) ([Figure 3](#fig3){ref-type="fig"}B), implicating the potential production of indigo dye. To further determine the identity of the blue pigment, a metabolite sample from the *E. coli* pET28a/*minA\** was submitted for HPLC assessment, generating a characteristic peak that was absent from the *E. coli* strain lacking *minA*\* (negative control) ([Figures 3](#fig3){ref-type="fig"}B, [S4](#mmc1){ref-type="supplementary-material"}B, and S4C). Further LC-MS analysis indicated that the LC peak produces an \[M + H\]^+^ ion at *m/z* 249.0615, and corresponding fragment ions at *m/z* 216.7811 and 231.9472, consistent with those of indigoidine ([Figures S4](#mmc1){ref-type="supplementary-material"}D and S4E). Hence, this demonstrated that the single NRPS (MinA)-mediated pathway is sufficient to support indigoidine biosynthesis.Figure 3*In Vivo* and *In Vitro* Reconstitution of the MinA Mediated Assembly Line(A) Schematic of the MinA-mediated assembly line for indigoidine biosynthesis.(B) Engineered production of indigoidine in *E. coli*. Top, the target metabolite (blue) produced by related strains. Bottom, HPLC analysis of the target metabolite indigoidine produced by related *E. coli* strains. pET28a/*indC*, extracted metabolite of *E. coli* BAP1 containing *indC* (indigoidine synthetase gene from *S. chromofuscus* ATCC 49982) as positive control; pET28a/*minA*\*, extracted metabolite of *E. coli* BAP1 containing *minA*\*; pET28a, extracted metabolite of *E. coli* BAP1 containing pET28a as negative control.(C) The extracted enzymatic products of the MinA reactions. Complete, the MinA reaction with all essential factors added; -Mg^2+^, the MinA reaction without adding exogenous Mg^2+^; -FMN, the MinA reaction without adding exogenous FMN; -L-Gln, the MinA reaction without L-glutamine added; -ATP, the MinA reaction without ATP added; -O~2~, the MinA reaction under N~2~ atmosphere.(D) HPLC analysis of the related MinA reactions. The characteristic \[M + H\]^+^ ion of indigoidine was also indicated on this panel, and the information for related samples corresponds to that in panel C.See also [Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}; [Tables S1](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}.

To reconstitute MinA activity *in vitro*, we over-expressed and purified the MinA protein from *E. coli*. The purified MinA shows bright yellow color ([Figures S4](#mmc1){ref-type="supplementary-material"}F and S4G), a typical feature of a flavin-dependent protein, as confirmed by LC-MS analysis ([Figures S4](#mmc1){ref-type="supplementary-material"}H and S4I). Enzymatic assays with the recombinant MinA produced an obvious blue color, implicating the production of indigoidine ([Figures 3](#fig3){ref-type="fig"}C and 3D), whose identity is further confirmed by LC-MS analysis ([Figure S4](#mmc1){ref-type="supplementary-material"}J). The *in vitro* reaction without enzyme added (negative control) was unable to generate the blue-colored product, and the enzyme reactions in the absence of L-glutamine, ATP, or O~2~ also generate similar negative results ([Figure 3](#fig3){ref-type="fig"}D). Furthermore, the purified MinA has only partial activity without an exogenous addition of FMN or Mg^2+^ ([Figures 3](#fig3){ref-type="fig"}D and [S4](#mmc1){ref-type="supplementary-material"}K--S4M) and indicates the preference to relative low temperatures (18°C of all temperatures tested) ([Figures S4](#mmc1){ref-type="supplementary-material"}N--S4P and S4R). Subsequently, we tested the substrate flexibility for MinA against the unnatural isomer D-glutamine with negative result ([Figures S4](#mmc1){ref-type="supplementary-material"}Q and S4R). These combined data substantially established that divergent biosynthesis of MIN and indigoidine is mediated by the NRPS (MinA) pathway, in which the compound **1** is likely converted to indigoidine via a non-enzymatic spontaneous reaction.

The potential pathways mediated by MinA homologs, as shown by *in silico* analysis, are actually more widely distributed than we initially imagined. In addition, there is also a high degree of diversity at the genetic level ([Figure S5](#mmc1){ref-type="supplementary-material"}). Earlier studies reported that indigoidine production affects the pathogenicity of the plant pathogen *Dickeya dadantii* ([@bib23]). In the present study, we tentatively propose that this bacterium could perform its pathogenic role by the coupled production of a potential MIN-related compound ([Figure S5](#mmc1){ref-type="supplementary-material"}), and it is of great interest for future study to elucidate such pathogenic mechanism at the molecular level.

MinC~N~ Is Responsible for the Final Dephosphorylation Step, and MinD Functions as a Uracil Phosphoribosyltransferase (UPRTase) {#sec2.4}
-------------------------------------------------------------------------------------------------------------------------------

*In silico* analysis showed that MinC is a two-domain enzyme, consisting of an *N-*terminal phosphatase domain and a *C-*terminal domain of undefined function (we have not yet determine the characteristic properties of MinC~C~ in the present study) ([Figures S6](#mmc1){ref-type="supplementary-material"}A and S6B), and that in some cases these are separated into two independent proteins ([Figure S6](#mmc1){ref-type="supplementary-material"}A). To determine if MinC~N~ catalyzes the final dephosphorylation step ([Figure 4](#fig4){ref-type="fig"}A), we over-expressed and purified the protein from *E. coli* to near homogeneity ([Figure S6](#mmc1){ref-type="supplementary-material"}C). This was assayed *in vitro* against the substrate MIN-MP, which is supplied by the Udk (uridine kinase from *Bacillus subtilis*, GenBank: QBJ70019.1) ([Table S6](#mmc1){ref-type="supplementary-material"})-catalyzed reaction ([Figures S6](#mmc1){ref-type="supplementary-material"}D--S6H). LC-MS analysis of the *in vitro* reaction products indicated that the MinC~N~ reaction is capable of generating a characteristic \[M + H\]^+^ ion at *m/z* 246.0601, with major fragment ions at *m/z* 155.9384, 210.1541, and 228.0651, consistent with those of the authentic MIN standard ([Figures 4](#fig4){ref-type="fig"}B and [S6](#mmc1){ref-type="supplementary-material"}I--S6K). This characteristic MIN peak was absent from the reaction without MinC~N~ added ([Figures 4](#fig4){ref-type="fig"}B and [S6](#mmc1){ref-type="supplementary-material"}L). Hence, these data support the hypothesis that MinC~N~ is responsible for the final dephosphorylation step during MIN biosynthesis.Figure 4Functional Characterization of MinC~N~*/*MinD as Phosphatase/UPRTase(A) Schematic of MinC~N~-catalyzed reaction. Udk, uridine kinase (GenBank: QBJ70019.1) from *Bacillus subtilis*; MIN-5′-MP, MIN-5′-monophosphate.(B) LC-HRMS analysis of the Udk/MinC~N~ reactions. MIN Std, the authentic standard of MIN; +Udk, the Udk catalyzed reaction to form MIN-MP; -Udk, the reaction without Udk added as negative control; (+Udk)+MinC~N~, the Udk reaction, proceeded for 4 h, with further addition of MinC~N~ for another 1 h; (+Udk)-MinC~N~, the Udk reaction (proceeded for 4 h) without further addition of MinC~N~ (also incubated for another 1 h). The characteristic \[M + H\]^+^ ions of MIN and MIN-MP are indicated as well in this panel for related peaks.(C) Schematic of MinD-catalyzed reaction. PRPP, phosphoribosyl pyrophosphate.(D) HPLC traces of the MinD reactions. Uracil Std, the authentic standard of uracil; UMP Std, the authentic standard of UMP; +MinD, the MinD reaction using uracil and PRPP as substrates; -MinD, the reaction without MinD added as negative control. The characteristic \[M + H\]^+^ ions of UMP/uracil are also indicated in this panel.See also [Figures S6](#mmc1){ref-type="supplementary-material"} and [S7](#mmc1){ref-type="supplementary-material"}; [Tables S1](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}.

Bioinformatic analysis suggested that *minD* encodes an UPRTase, which are generally involved in the pyrimidine salvage pathway by catalyzing the reaction between uracil and phosphoribosylpyrophate (PRPP) to regenerate UMP ([@bib26]) ([Figures 4](#fig4){ref-type="fig"}C and [S7](#mmc1){ref-type="supplementary-material"}A). To investigate the enzymatic role of MinD, it was over-expressed and purified from *E. coli* ([Figure S7](#mmc1){ref-type="supplementary-material"}B), and the corresponding activity was determined *in vitro*. As anticipated, HPLC analysis showed that the MinD-catalyzed reaction could generate a peak for UMP, corresponding to an authentic standard, which was absent from the negative control ([Figure 4](#fig4){ref-type="fig"}D). Further LC-MS analysis indicated that the target peak gave rise to a characteristic \[M + H\]^+^ ion for UMP at *m/z* 325.0428, and main fragment ions at *m/z* 212.9202 and 227.0645, completely consistent with those of the UMP authentic standard ([Figures S7](#mmc1){ref-type="supplementary-material"}C--S7E). These results establish that MinD functions as an UPRTase for the synthesis of UMP.

Divergent Biosynthesis of MIN and Indigoidine Is Mediated by an NRPS-Associated Assembly Line {#sec2.5}
---------------------------------------------------------------------------------------------

Previous isotopic feeding experiments had showed that L-glutamate is incorporated into the oxazine ring of MIN ([@bib9], [@bib29]), whereas its ribosyl moiety is from D-ribose ([@bib8]). In the present work, this mechanism is shown to be reasonable. MIN biosynthesis is confirmed to be initiated by MinA, which specifically selects L-glutamine as substrate, and the tethered amino acid is then dehydrogenated under strict and precise stereospecificity/regiospecificity at the C2-C3 positions by the oxidase domain (Ox domain). Subsequently, compound **1** is released by hydrolysis of the TE domain. Compound **1**, as a key branch intermediate, is proposed to be converted to indigoidine by a spontaneous oxidative coupling reaction ([Figure 5](#fig5){ref-type="fig"}). Simultaneously, this intermediate could be tautomerized by the Tau domain to form **2**, which is modified by the MinB *C-*glycosynthase to produce **3**. Compound **3** subsequently undergoes an unusual oxidative deamination and recombination reaction catalyzed by MinC~C~ to generate MIN-MP, which is followed by the final dephosphorylation step to complete MIN biosynthesis ([Figure 5](#fig5){ref-type="fig"}). MinC~C~ features a DUF4243 domain, which is also present in a Baeyer-Villiger oxidase AflY of the aflatoxin biosynthetic pathway ([@bib3]). In this respect, MinC~C~ represents a novel type of Baeyer-Villiger oxidase catalyzing an unprecedented and intriguing oxidative deamination and recombination reaction, and relevant studies to investigate its enzymatic logic are now underway in our laboratory.Figure 5Proposed Pathway for the Biosynthesis of MIN and IndigoidineProposed pathway for the divergent biosynthesis of MIN and indigoidine. See also [Figure S5](#mmc1){ref-type="supplementary-material"}.

Indigoidine is a well-established microbial metabolite known for over half a century. However, it has now been established for the first time that this pigment is actually associated with the co-production of the *C*-nucleoside MIN. Accordingly, it is possible that indigoidine biosynthesis from an increasing number of potential pathways may be associated with related unknown *C-*nucleoside molecules, because analogs of the MinA-MinB pair are in several cases concomitantly present in the specific gene clusters ([Figure S5](#mmc1){ref-type="supplementary-material"}). L-glutamate is the common precursor for the aglycon of the *C-*nucleoside antibiotics, including MIN, formycin, pyrazofurin, and showdomycin ([@bib29]), which until recently have been unexplored at the molecular level ([@bib6], [@bib21], [@bib27], [@bib32]). Hence, we propose that further insight into the molecular logics underlying the biosynthesis of *C-*nucleoside antibiotics will identify diverse and unique enzymes for potential synthetic biology purposes.

MinC~N,~ MinD, and MinT Functioning as the Safeguard Enzymes Constitute a Collaborative Self-Resistance System during MIN Biosynthesis {#sec2.6}
--------------------------------------------------------------------------------------------------------------------------------------

The assignment of MinD as a UPRTase raises an interesting open question: what is the functional role of this enzyme during MIN biosynthesis? Considering the fact that MIN is also active against *Streptomyces*, we tentatively propose that it may play a key role in self-resistance during MIN biosynthesis by employing an unprecedented mechanism. We therefore introduced *minD* into *S. coelicolor* M1154 to determine whether it mediates a safeguard role. In contrast to this expectation, the recombinant *s*train (M1154::pIB139*minD*) had no apparent resistance to MIN (10 μg/mL). Accordingly, we re-examined the MIN gene cluster and noticed that *minC*~N~ and *minT* are also potential contributors to the self-resistance system. To test the assumption, we individually introduced these two genes into *S. coelicolor* M1154. However, neither gene was capable of supporting the growth of the corresponding *S. coelicolor* M1154 recombinants in the presence of MIN (10 μg/mL, the minimal inhibitory concentration against *S. coelicolor* M1154-derived negative controls in this study) ([Figures 6](#fig6){ref-type="fig"}A and 6B).Figure 6Proposed Self-Resistance Mechanism for the Biosynthesis of MIN(A) Plate-grown experiments for *S. coelicolor* M1154 recombinants containing related genes. For the first two plates, the recombinant incubated for 36 h (in the related square) corresponds to each other. For plates 2--4, it means the identical plate that was incubated for different time (marker at the bottom of each plate); MIN (-), the MIN-negative plate; MIN (10 μg/mL), the plate containing MIN at a final concentation of 10 μg/mL. The recombinant in the related square corresponds to that described as below.(B) Representational map for the plate-grown experiments. pIB139, *S. coelicolor* M1154 containing the empty vector pIB139; pIB139D, *S. coelicolor* M1154 containing pIB139/*minD*; pIB139T, *S. coelicolor* M1154 containing pIB139/*minT*; pIB139C~N~, *S. coelicolor* M1154 containing pIB139/*minC*~N~; pIB139DT, *S. coelicolor* M1154 containing pIB139/*minDT*; pIB139DC~N~, *S. coelicolor* M1154 containing pIB139/*minDC*~N~; pIB139TC~N~, *S. coelicolor* M1154 containing pIB139/*minTC*~N~; pIB139DTC~N~, *S. coelicolor* M1154 containing pIB139/*minDTC*~N~.(C) The relative abundance of the UMP concentrations *in vivo* for the strains at different growth stages (48 and 72 h). pSET152, the sample of *S. coelicolor* M1154::pSET152 (blue); pCHW301, the sample of *S. coelicolor* M1154::pCHW301 (red); "RA" denotes relative abundance. Data are represented as mean ± SEM.(D) Proposed collaborative self-resistance system during MIN biosynthesis. Three enzymes, including MinC~N~, MinT, and MinD, collaborate to fulfill the mission of self-resistance during MIN biosynthesis, and MinD, acting as the key safeguard enzyme, employs an unprecedented strategy of substrate competition to achieve self-resistance during MIN biosynthesis.See also [Figure S7](#mmc1){ref-type="supplementary-material"} and [Table S1](#mmc1){ref-type="supplementary-material"}.

These results suggested that some combination of *minC*~N~, *minD*, and *minT* may collaborate to fulfill the self-resistance role, and we accordingly introduced these different combinations into *S. coelicolor* M1154. Notably, several of these combinations are able to support the effective growth of the corresponding *S. coelicolor* M1154 recombinants in the presence of MIN, whereas the introduced single *minC*~N~, *minD*, or *minT* could not maintain the apparent growth of the related recombinants. It was also observed that *minD* has a greater contribution to the self-resistance system, and the combination (containing *minC*~N~, *minD*, and *minT*) could maintain the optimal growth status for the counterpart recombinant ([Figures 6](#fig6){ref-type="fig"}A and 6B). Together, these data demonstrate that *minD,* in collaboration with *minC*~N~ and *minT,* determines the functional role *in vivo* constituting the self-resistance system during MIN biosynthesis.

Biosynthesis of MIN Employs a Substrate-Competition Strategy for Self-Resistance {#sec2.7}
--------------------------------------------------------------------------------

A further relevant question is how MIN executes its inhibitory role *in vivo*? We propose that similar to many other nucleoside analogs ([@bib10]), the phosphorylated form (MIN-MP) of MIN functions as the active inhibitory molecule. This is also supported by the discovery of kinases (from *S. coelicolor* M1154 and *Bacillus subtilis*) capable of recognizing MIN as substrates ([Figures S6](#mmc1){ref-type="supplementary-material"}C--S6H), and the fact that MinD (UPRTase) may function as a safeguard enzyme by enhancing the *in vivo* UMP pool of microbial cells. To test this suggestion, we conducted bioassays using *Bacillus subtilis* as an indicator strain by exogenous addition of uridine and MIN at different concentration ratios. This strain showed resistance to MIN in the co-presence of relative high concentration of uridine ([Figure S7](#mmc1){ref-type="supplementary-material"}F), implying that uridine, which is efficiently metabolized to UMP *in vivo*, is capable of partly alleviating the inhibition of MIN. Moreover, the *in vivo* UMP concentrations for the *S. coelicolor* M1154 recombinants, as determined by LC-high-resolution MS (HRMS), are considerably higher than those of the negative control (*S. coelicolor* M1154::pSET152) ([Figures 6](#fig6){ref-type="fig"}C and [S7](#mmc1){ref-type="supplementary-material"}G), providing further support for the self-resistance model employed in MIN biosynthesis. In contrast, the *in vivo* MIN-MP (the active form of MIN), as indicated by LC-HRMS, is undetectable due to the relatively much lower concentration (if compared with that of UMP) ([Figures S7](#mmc1){ref-type="supplementary-material"}H and S7I). These data support the hypothesis that the inhibitory role of MIN is attenuated by UMP by an unprecedented substrate-competition mechanism.

Biosynthetic bacteria have evolved several strategies for self-resistance during natural product production, often transporting the metabolite out of the producer cell upon its synthesis, or by modification of natural products or the target site ([@bib33]). The substrate-competition strategy for self-resistance presented here is, to the best of our knowledge, unique, but it may be broadly exploited for microbial natural products biosynthesis. In this self-resistance system, the active inhibitory molecule MIN-MP is immediately dephosphorylated to form the end product MIN, most of which will be promptly transported out of the producer cells. MinD, therefore, functions as a safeguard enzyme that responds to sub-inhibitory concentrations of MIN-MP by increasing the UMP pool *in vivo*, thereby achieving the self-resistance for the producer cell ([Figure 6](#fig6){ref-type="fig"}D).

Limitations of the Study {#sec2.8}
------------------------

In this study, we have uncovered that divergent biosynthesis of MIN and indigoidine is mediated by an NRPS enzyme and have demonstrated that an unprecedented collaborative self-resistance system is employed for MIN biosynthesis. However, the precise mechanism of how MIN executes its inhibitory role will require further study. Further studies will also be required to understand the enzymatic formation of the oxazine ring substituent of MIN.

Methods {#sec3}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Data and Code Availability {#appsec1}
==========================

The DNA sequence is deposited in the GenBank database under individual accession numbers MK122964 (for the *min* gene cluster from *S. hygrocsopicus* JCM 4712) and MN397911 (for the genes *orf3815* and *orf3816* from *S. hygrocsopicus* JCM 4712).
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Document S1. Transparent Methods, Figures S1--S7, and Tables S1--S6
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